Evidence map›Paper›PMID 32030595›Full record

ArticleAdministration and policy in mental health2020

The Antipsychotic Medication Management Fidelity Scale: Psychometric properties.

Torleif Ruud, Karin Drivenes, Robert E Drake, Vegard Øksendal Haaland, Matthew Landers, Bjørn Stensrud, Kristin S Heiervang, Lars Tanum, Gary R Bond

Registry-linked trialAbstract read
In one paragraph

Article in Administration and policy in mental health, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03271242 (A Pairwise Randomized Study on Implementation of Guidelines and Evidence Based Treatments of Psychoses), which is not on this map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03271242 completednot on this map

A Pairwise Randomized Study on Implementation of Guidelines and Evidence Based Treatments of Psychoses

TypeobservationalSponsorUniversity Hospital, AkershusRan2016 to 2018Enrolled325ConditionsPsychotic DisordersArmsSystematic implementation support, No implementation support
3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Experiential and Medical Knowledge of Shared Decision-Making: Exploring Clinician and Service User Perspectives in NHS Community Mental Health Services.Health expectations : an international journal of public participation in health care and health policy · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Fidelity Scale: From Black Box to Holy Grail.Administration and policy in mental health · 2020
    Article
  11. Measuring Fidelity to Evidence-Based Practices: Psychometrics.Administration and policy in mental health · 2020
    Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Torleif RuudDivision of Mental Health Services, Akershus University Hospital, Lørenskog, Norway. torleif.ruud@medisin.uio.no.ORCID 0000-0002-4821-1267
Karin DrivenesDivision of Mental Health, Sørlandet Hospital, Kristiansand, Norway.
Robert E DrakeWestat, Lebanon, NH, USA.
Vegard Øksendal HaalandSørlandet Hospital, Kristiansand, Norway.
Matthew LandersDuke University, Durham, NC, USA.
Bjørn StensrudDivision of Mental Health, Innlandet Hospital Trust, Brumunddal, Norway.
Kristin S HeiervangDivision of Mental Health Services, Akershus University Hospital, Lørenskog, Norway.
Lars TanumDivision of Mental Health Services, Akershus University Hospital, Lørenskog, Norway.
Gary R BondWestat, Lebanon, NH, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The paper describes the Antipsychotic Medication Management Fidelity Scale and its psychometric properties, including interrater reliability, frequency distribution, sensitivity to change and feasibility. Fidelity assessors conducted fidelity reviews four times over 18 months at eight sites receiving implementation support for evidence-based antipsychotic medication management. Data analyses shows good to fair interrater reliability, adequate sensitivity to change over time and good feasibility. At 18 months, item ratings varied from poor to full fidelity on most items. Use of the scale can assess fidelity to evidence-based guidelines for antipsychotic medication management and guide efforts to improve practice. Further research should improve and better calibrate some items, and improve the procedures for access to information.Trial registration: ClinicalTrials.gov Identifier: NCT03271242.

Indexed as

Antipsychotic AgentsData CollectionHumansMedication Therapy ManagementPsychometricsReproducibility of ResultsAntipsychotic AgentsAntipsychotic medicationEvidence-based practiceFidelity scaleImplementationPsychosis

Identifiers

PMID32030595
PMCPMC7547997

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.